Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits

被引:109
作者
Arishiro, Kumiko
Hoshiga, Masaaki
Negoro, Nobuyuki
Jin, Denan
Takai, Shinji
Miyazaki, Mizuo
Ishihara, Tadashi
Hanafusa, Toshiaki
机构
[1] Osaka Med Coll, Dept Internal Med 1, Osaka 5698686, Japan
[2] Osaka Med Coll, Dept Pharmacol, Osaka 5698686, Japan
关键词
D O I
10.1016/j.jacc.2006.11.043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We sought to examine the effect of angiotensin receptor blocker (ARB) on the formation of lesions in the aortic valves of hypercholesterolemic rabbits. Background Recently, atherosclerosis has been recognized as a mechanism that is responsible for calcific aortic stenosis. The effect of ARBs might help to prevent aortic stenosis because they have multiple antiatherosclerotic effects. Methods Male Japanese white rabbits (n = 36) were separated as follows: control with chow diet (C) and vehicle (V) groups, both of which were fed a 1% cholesterol diet for 8 weeks, and an ARB group (A), which was fed a 1% cholesterol diet for 8 weeks with ARB (olmesartan, 1 mg/kg,/day) for the last 4 weeks. Results This dose of olmesartan did not affect either blood pressure or cholesterol levels. Dietary cholesterol induced fatty deposition with macrophage accumulation and osteopontin coexpression in valve leaflets, whereas ARB decreased macrophage accumulation (% area: V, 9.3 +/- 0.34; A, 1.4 +/- 0.30; p = 0.003) and osteopontin expression (p = 0.017). Angiotensin-converting enzyme was also up-regulated in V and decreased by olmesartan (p = 0.015). Immunohistochemistry with anti-CD31 antibody revealed that dietary cholesterol disrupted and olmesartan preserved endothelial integrity on the lesion-prone aortic side of the valve (% CD31-positive circumference: V, 30 +/- 3.7; A, 62 +/- 4.8; p = 0.003). Numbers of alpha-smooth muscle actin-positive myofibroblasts were increased in V and decreased by olmesartan (p = 0.003). Real-time polymerase chain reaction revealed that increased amounts of messenger ribonucleic acid for osteoblast-specific transcription factor core binding factor alpha-1 in V were diminished by olmesartan. Conclusions Atherosclerotic changes in the aortic valves of rabbits fed with cholesterol were inhibited by ARB, whereas endothelial integrity was preserved and transdifferentiation into myofibroblasts and/or osteoblasts in valve leaflets was inhibited.
引用
收藏
页码:1482 / 1489
页数:8
相关论文
共 36 条
[1]   Induction of myocardial biglycan in heart failure in rats -: an extracellular matrix component targeted by AT1 receptor antagonism [J].
Ahmed, MS ;
Oie, E ;
Vinge, LE ;
Yndestad, A ;
Andersen, GO ;
Andersson, Y ;
Attramadal, T ;
Attramadal, H .
CARDIOVASCULAR RESEARCH, 2003, 60 (03) :557-568
[2]   Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community [J].
Bellamy, MF ;
Pellikka, PA ;
Klarich, KW ;
Tajik, AJ ;
Enriquez-Sarano, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (10) :1723-1730
[3]   Guidelines for the management of patients with valvular heart disease - Executive summary - A report of the American College of Cardiology American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease) [J].
Bonow, RO ;
Carabello, B ;
de Leon, AC ;
Edmunds, LH ;
Fedderly, BJ ;
Freed, MD ;
Gaasch, WH ;
McKay, CR ;
Nishimura, RA ;
O'Gara, PT ;
O'Rourke, RA ;
Rahimtoola, SH ;
Ritchie, JL ;
Cheitlin, MD ;
Eagle, KA ;
Gardner, TJ ;
Garson, A ;
Gibbons, RJ ;
Russell, RO ;
Ryan, TJ ;
Smith, SC .
CIRCULATION, 1998, 98 (18) :1949-1984
[4]   Angiotensin II stimulated expression of transforming growth factor-beta(1) in cardiac fibroblasts and myofibroblasts [J].
Campbell, SE ;
Katwa, LC .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (07) :1947-1958
[5]   A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis [J].
Cowell, SJ ;
Newby, DE ;
Prescott, RJ ;
Bloomfield, P ;
Reid, J ;
Northridge, DB ;
Boon, NA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (23) :2389-2397
[6]   Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-κB, in mononuclear cells of normal subjects:: Evidence of an antiinflammatory action [J].
Dandona, P ;
Kumar, V ;
Aljada, A ;
Ghanim, H ;
Syed, T ;
Hofmayer, D ;
Mohanty, P ;
Tripathy, D ;
Garg, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09) :4496-4501
[7]   Cholesterol in vascular and valvular calcification [J].
Demer, LL .
CIRCULATION, 2001, 104 (16) :1881-1883
[8]   Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice [J].
Dol, F ;
Martin, G ;
Staels, B ;
Mares, AM ;
Cazaubon, C ;
Nisato, D ;
Bidouard, JP ;
Janiak, P ;
Schaeffer, P ;
Herbert, JM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (03) :395-405
[9]   Induction of local angiotensin II-producing systems in stenotic aortic valves [J].
Helske, S ;
Lindstedt, KA ;
Laine, M ;
Mäyränpää, M ;
Werkkala, K ;
Lommi, J ;
Turto, H ;
Kupari, M ;
Kovanen, PT .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) :1859-1866
[10]   THE SURFACE ANATOMY OF THE HUMAN AORTIC-VALVE AS REVEALED BY SCANNING ELECTRON-MICROSCOPY [J].
HURLE, JM ;
COLVEE, E ;
FERNANDEZTERAN, MA .
ANATOMY AND EMBRYOLOGY, 1985, 172 (01) :61-67